| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
info@bocsci.com |
COR 170 manufacturers
- COR 170
-
- $1520.00
-
2026-05-11
- CAS:1048039-15-1
- Purity:
- Supply Ability: 10g
|
| | COR 170 Basic information |
| Product Name: | COR 170 | | Synonyms: | COR 170;N-(Adamant-1-yl)-4-oxo-1-pentyl-6-phenyl-1,4-dihydroquinoline-3-carboxamide;3-Quinolinecarboxamide, 1,4-dihydro-4-oxo-1-pentyl-6-phenyl-N-tricyclo[3.3.1.13,7]dec-1-yl- | | CAS: | 1048039-15-1 | | MF: | C31H36N2O2 | | MW: | 468.63 | | EINECS: | | | Product Categories: | | | Mol File: | 1048039-15-1.mol |  |
| | COR 170 Chemical Properties |
| storage temp. | Store at RT | | solubility | Soluble to 100 mM in ethanol and to 20 mM in DMSO | | form | Powder |
| | COR 170 Usage And Synthesis |
| Description | Selective inverse agonist of CB2 receptors (Ki values are 3.8 and >10,000 nM for CB2 and CB1, respectively). | | Uses | COR170 (11u) is a selective CB2 inverse-agonist which is a 4-quinolone-3-carboxylic acid derivative with a Ki value of 3.8 nM for CB2 receptor. COR170 can be used for the research of inflammation and neuroprotection[1][2][3]. | | in vivo | COR170 (11u) (1.5-6 mg/kg; i.p, once) reduces the late phase nociceptive behaviour induced by formalin[3]. | Animal Model: | Mice with formalin (1.25%, 30 μL) injections[3] | | Dosage: | 1.5, 3 and 6 mg/kg | | Administration: | Intraperitoneal injection; 1.5, 3 and 6 mg/kg for once | | Result: | Reduced the late phase nociceptive behaviour induced by formalin with a 6 mg/kg dose and 10 min before formalin and abolished the analgesic effect from GW405833 which is a CB2 receptor partial agonist. |
| | storage | Store at RT | | References | [1] Contartese A, et al. A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury. Pharmacol Res. 2012 Dec;66(6):555-63. DOI:10.1016/j.phrs.2012.08.003
[2] Pasquini S, et al. Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo. J Med Chem. 2008 Aug 28;51(16): DOI:10.1021/jm800552f
[3] Cascio MG, et al. In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB(2) receptor inverse agonists. Pharmacol Res. 2010 Apr;61(4):349-54. DOI:10.1016/j.phrs.2009.11.011 |
| | COR 170 Preparation Products And Raw materials |
|